| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.4 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.023 | 0.4 |